Literature DB >> 12933487

Spectrum of MRI appearances of untreated metastases of the liver.

Ioana-Maria Danet1, Richard C Semelka, Polytimi Leonardou, Larissa Braga, Georgeta Vaidean, John T Woosley, Masayuki Kanematsu.   

Abstract

OBJECTIVE: The purpose of our study was to identify the spectrum of MRI appearances of untreated liver metastases from different primary origins.
MATERIALS AND METHODS: Over a period of 52 months, we used our clinical information system to retrospectively identify the first MRIs obtained in 165 consecutive patients who had untreated liver metastases. All patients had histologic confirmation of the primary tumor. Liver metastases were confirmed at histologic examination, on imaging, or at clinical follow-up. MR sequences used included T1-weighted spoiled gradient-echo, T2-weighted half-Fourier acquisition single-shot turbo spin-echo, and serial gadolinium-enhanced spoiled gradient-echo imaging. Size, signal intensity characteristics, and pattern of enhancement of the metastases on MRIs were evaluated by two radiologists in consensus. Lesions were categorized by size: smaller than 1.5 cm, between 1.5 and 3.0 cm, and larger than 3.0 cm.
RESULTS: A total of 516 metastases (size range, 5-120 mm; mean, 28 mm) were assessed. Fifty-nine patients had hypervascular lesions, and 106 patients had hypovascular lesions. A significant difference in proportion of tumor vascularity was observed between the primary tumors described as classically hypervascular and those described as classically hypovascular (chi-square test for proportions of 70.8, p < 0.0001). The most common pattern was peripheral ring (72% of patients) seen on the arterial dominant phase images, with incomplete central progression (63%) seen on the delayed phase images. A hypointense ring seen in the periphery of the tumor during the delayed phase was the most common appearance in hypervascular metastases (27% patients) and was particularly conspicuous in patients with neuroendocrine and carcinoid tumors. Perilesional enhancement was common (47%), mostly seen in hypovascular metastases (92%). Generally, large lesions tended to show a peripheral ring or heterogeneous enhancement, and small lesions showed homogeneous enhancement.
CONCLUSION: MRI allows the identification of a wide spectrum of appearances of untreated liver metastases. The extent and pattern of enhancement of various histologic types of tumor are depicted on MRI.

Entities:  

Mesh:

Year:  2003        PMID: 12933487     DOI: 10.2214/ajr.181.3.1810809

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  44 in total

1.  Characterisation of small hypoattenuating hepatic lesions in multi-detector CT (MDCT) in patients with underlying extrahepatic malignancy: added value of contrast-enhanced MR images.

Authors:  Song-Ee Baek; Mi-Suk Park; Hye Sook Hong; Jin Young Choi; Yong Eun Chung; Joon Seok Lim; Myeong-Jin Kim; Ki Whang Kim
Journal:  Eur Radiol       Date:  2010-07-09       Impact factor: 5.315

2.  Magnetic resonance imaging: Review of imaging techniques and overview of liver imaging.

Authors:  Santhi Maniam; Janio Szklaruk
Journal:  World J Radiol       Date:  2010-08-28

3.  Diffusion-weighted images (DWI) without ADC values in assessment of small focal nodules in cirrhotic liver.

Authors:  Mai-Lin Chen; Xiao-Yan Zhang; Li-Ping Qi; Qing-Lei Shi; Bin Chen; Ying-Shi Sun
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

4.  Percutaneous Image-Guided Cryoablation of Hepatic Tumors: Single-Center Experience With Intermediate to Long-Term Outcomes.

Authors:  Daniel I Glazer; Servet Tatli; Paul B Shyn; Mark G Vangel; Kemal Tuncali; Stuart G Silverman
Journal:  AJR Am J Roentgenol       Date:  2017-09-27       Impact factor: 3.959

5.  Specific imaging characteristic of solitary necrotic nodule of the liver: Marked peripheral rim-like enhancement with internal hypointensity on longer delayed MRI.

Authors:  Jiayang Fang; Xiaoyuan Ma; Dexin Yu; Xiangxing Ma; Ying Xiang; Lijuan Guo
Journal:  Eur Radiol       Date:  2017-01-25       Impact factor: 5.315

6.  The value of gadoxetic acid-enhanced MRI for differentiation between hepatic microabscesses and metastases in patients with periampullary cancer.

Authors:  Seo-Youn Choi; Young Kon Kim; Ji Hye Min; Dong Ik Cha; Woo Kyoung Jeong; Won Jae Lee
Journal:  Eur Radiol       Date:  2017-03-24       Impact factor: 5.315

Review 7.  Hepatic nodules with arterial phase hyperenhancement and washout on enhanced computed tomography/magnetic resonance imaging: how to avoid pitfalls.

Authors:  Mimi Tang; Yin Li; Zhi Lin; Bingqi Shen; Mengqi Huang; Zi-Ping Li; Xuehua Li; Shi-Ting Feng
Journal:  Abdom Radiol (NY)       Date:  2020-11

8.  Time to Progression of Pancreatic Cancer: Evaluation with Multi-Detector Computed Tomography.

Authors:  Su Joa Ahn; Seung Joon Choi; Hyung Sik Kim
Journal:  J Gastrointest Cancer       Date:  2017-06

Review 9.  Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions.

Authors:  Ahmed Ba-Ssalamah; Martin Uffmann; Sanjai Saini; Nina Bastati; Christian Herold; Wolfgang Schima
Journal:  Eur Radiol       Date:  2008-09-23       Impact factor: 5.315

Review 10.  Distinguishing benign from malignant liver tumours.

Authors:  Jay P Heiken
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.